Hot Pharma stock to watch: ChemoCentryx Inc (NASDAQ: CCXI)
ChemoCentryx Inc (NASDAQ: CCXI), is responsible for the discovery and development of avacopan and owns and retains the commercial rights to the drug in the…
ChemoCentryx Inc (NASDAQ: CCXI), is responsible for the discovery and development of avacopan and owns and retains the commercial rights to the drug in the…
ChemoCentryx Inc (NASDAQ: CCXI) stock fell 13.91% on September 7th, 2018 after the company came up with the second quarter 2018 results. During the second…